A novel adoptive synthetic TCR and antigen receptor (STAR) T-Cell therapy for B-Cell acute lymphoblastic leukemia.
Wang J, Zhang X, Zhou Z, Liu Y, Yu L, Jia L, Yang J, Li J, Yu H, Li W, Liu G, Rui W, Zheng H, Zhao X, Lin X, Lu P.
Wang J, et al. Among authors: jia l.
Am J Hematol. 2022 Aug;97(8):992-1004. doi: 10.1002/ajh.26586. Epub 2022 May 12.
Am J Hematol. 2022.
PMID: 35491511
Free article.
Clinical Trial.